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Our understanding of the molecular mechanisms regulating 
endothelial cell behavior in bone vs. other organs has 
been challenging to date given the inaccessibility of blood 
vessels deep within the bone mineral and the difficulties 
associated with bone endothelial cell isolation. A recent 
study published by Ramasamy et al. (1), combined postnatal 
modification of endothelial cell specific Notch signals with 
improved immunohistochemical approaches and bone 
endothelial cell isolation, to highlight for the first time the 
presence of clear bone endothelial cell heterogeneity.
To date, the Notch pathway has been shown to be a 
highly conserved mechanism of cell fate determination and 
differentiation, regulating a wide variety of developmental 
processes. Notch signaling involves interactions between 
adjacent ligand-and receptor-expressing cells and allows 
for stimulation of different processes in neighboring cells. 
The role of Notch signaling in blood vessel sprouting 
provides an example of how Notch signals can determine 
cell fate, and was first described in the study of angiogenesis 
of the mouse retina (2). The process of angiogenesis or 
blood vessel sprouting from pre-existing vessels involves 
the continued interaction between “tip” and “stalk” cells 
and Notch signaling has been shown to be central to the 
formation of these distinct endothelial cell identities. 
Vascular endothelial growth factor (VEGF) binding to 
VEGF receptor 2 (VEGFR2) causes an up-regulation of 
the Notch ligand Delta-like 4 (Dll4) which interacts with 
Notch1 receptors on adjacent endothelial cells. This leads 
to the down-regulation of VEGFR2 in those cells, whereby 
only one leading tip cell expresses high VEGFR2 levels. 
Therefore, the Notch signaling pathway can limit the 
angiogenic behavior of endothelial cells within developing 
blood vessel sprouts, in part through the modulation of 
the VEGF signaling pathway. This suppression of tip-cell 
features in stalk cells by Dll4/Notch and lateral inhibition of 
VEGFR2 has similarly been described during development 
and in tumor growth (3,4).
Bone is highly vascularized and the blood supply is 
critical during periods of rapid growth, remodeling, 
and repair. Extensive published data demonstrates the 
depth and complexity of the reciprocal co-dependency 
which exists between the vascular and skeletal tissues 
in which each tissue provides morphogenetic signals or 
environmental cues crucial for the other’s development. To 
effectively couple bone formation with angiogenesis, bone 
forming osteoblast cells produce pro-angiogenic factors 
such as VEGF in response to a range of factors including 
mechanical strain, hypoxia, estrogen and prostaglandins 
[reviewed in (5)]; and conditional loss of early osteoblast 
VEGF expression in vivo results in reduced endothelial cell 
number in bone and an osteoporotic phenotype of reduced 
bone mass and increased marrow fat (6). Given the 
important roles for VEGF in bone and the involvement 
of Notch in the negative regulation of VEGF signaling in 
other tissues Ramasamy and colleagues (1) investigated the 
function of Notch signaling in coupling angiogenesis with 
osteogenesis.
The study describes the influence of in vivo endothelial 
cell specific deletion of Rbpj, which encodes an essential 
mediator of Notch-induced gene transcription. In contrast 
to the positive effects of Notch deletion on retinal 
angiogenesis, these mutant animals showed a decrease in 
the total number of proliferating endothelial cells in bone 
with the patterning of the vessels disrupted and filopodia 
from mutant vessels appearing disorganized. This defective 
angiogenesis was accompanied with a bone phenotype 
including shortened long bones, disorganization of the 
metaphysis with large irregular lacunae, and a lack of clearly 
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separated trabeculae. Micro-computed tomography analyses 
also showed significant loss in bone mass, but there were 
no differences in osteoclast numbers. In the growth plate 
hypertrophic zones were enlarged and VEGF expression by 
mature chondrocytes was reduced.
Mesenchymal Notch expression has been shown 
to promote proliferation and suppress osteoblast 
differentiation (7,8) and to test whether Dll4 may signal 
through osteoblasts Rbpj was also deleted in Collagen 
1 expressing cells and the same experimental schedule 
undertaken, with no apparent defects in either metaphyseal 
vasculature or osteoprogenitor cells present in these mutant 
animals. Therefore, Notch signaling effects appear to be 
endothelial cell specific and cell autonomous, coupling 
angiogenesis to osteogenesis. To investigate the factors 
acting on osteoblasts via Notch, endothelial cells were 
isolated from bones of Notch gain of function mutant mice 
and control animals with a candidate approach utilized 
to identify gene expression changes. Noggin, a secreted 
antagonist of bone morphogenic proteins (BMPs) was 
found to be 40-fold higher in the gain of function mutant 
mice than in controls. Osteoblast specific Noggin mutants 
developed a skeletal phenotype similar to Rbjb endothelial 
cell knock outs, and daily injection of recombinant Noggin 
to Rbjb mice improved bone formation and restored 
metaphysis organization.
These results have demonstrated for the first time, the 
presence of a distinct population of endothelial cells which 
exist and function within the bone microenvironment 
and utilize Dll4/Notch signaling in a positive manner. In 
addition to the underlying mechanistic differences described 
in bone endothelial behavior a unique phenotype of the 
blood vessels in bone was also shown. The metaphyseal 
vessels in the long bones were found to point towards 
the chondrocytes of the growth plate (which produce 
VEGF), with columns linked by tubular arches with 
blind-ended, bulb shape protrusions. These arch vessels 
did have extended filopodia pointing towards the growth 
plate but perfusion experiments showed that they were 
fully lumenized. Therefore, the leading endothelial cell 
structures in bone were dissimilar to the angiogenic sprouts 
present in tissues which utilize Dll4/Notch-mediated lateral 
inhibition of VEGFR2 signaling.
The utilization of negative or positive regulation of 
angiogenesis by Dll4/Notch in different tissues is intriguing 
and may be explained in part by environmental influences 
controlling the expression and availability of tissue derived 
factors. We know from tissues where spatial interactions 
with vasculature are clearly defined, that Dll4/Notch 
signaling is stimulated in the first instance by tissue-derived 
VEGF and its cellular actions will depend on matrix binding 
and the spatial distribution and extracellular gradients of 
VEGF, which acts as a chemoattractant to direct capillary 
growth (9,10).
Whether distinct VEGF gradients are utilized within 
the bone microenvironment remains unclear but the 
production and localization of bone-derived VEGF 
could contribute to the differences in bone endothelial 
cell phenotype and Dll4/Notch signaling described by 
Ramasamy and colleagues (1). Osteoblasts are known to be 
an important source of VEGF which can exert paracrine, 
autocrine (11) and intracrine (6) effects on both endothelial 
and bone cell behavior, coupling angiogenesis to bone 
remodeling. Bones mechanical responsiveness drives the 
remodeling process and has been shown to regulate blood 
vessel growth by the production of VEGF and regulation 
of VEGFR2 signaling (12) in osteoblasts. Interestingly, 
altered mechanical signals in bone can modulate alternative 
splicing of VEGF mRNA in osteoblasts which results in 
the production of VEGF isoforms which together can 
form VEGF gradients. Expression of short freely diffusible 
VEGF isoforms 121,165 for example, have been shown 
to be expressed under low mechanical frequency while 
matrix-bound larger VEGF isoforms 206,189,165,145 
are expressed under high mechanical frequency in human 
osteoblasts (13). The spatial distribution of VEGF has 
been shown to regulate the cell shape of sprouting vessels 
in mouse retina (9). Whether a VEGF gradient established 
in response to mechanical influences and remodeling 
requirements does exist in bone and can influence the 
morphology and Notch signaling of blood vessels is an 
interesting question for future interrogation.
Reduced VEGF has been linked to osteoporosis (6,14,15) 
and irregular vascular supply to bone is associated with age 
and other bone pathologies. Changes in bone endothelial 
cell expression of DII4/Notch/Noggin and their control of 
osteogenesis during disease, aging or fracture repair provide 
a novel and exciting area for further research. Identification 
of unique endothelial cell phenotypes and signaling 
responses which can influence osteogenesis could now bring 
the vasculature to the forefront as an innovative means to 
therapeutically promote bone anabolism.
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